Need Help?

Genomic characterization of metastatic breast cancers

While large efforts have been done to characterize early breast cancer, little is known about the genomic landscape of metastatic breast cancer. In the present study, we performed whole exome sequencing of 629 metastatic breast cancers, in order to identify new candidate targets and better stratify patients eligible for innovative therapies.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001004772 Illumina NovaSeq 6000 1238
Publications Citations
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Genome Med 13: 2021 87